Today's top story

Pharmaceutical companies face wait on EU AI regulation question

With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the process of drug development need clarity on whether the rules will apply to them.

Artificial Intelligence

NACHRICHTEN

Oft gelesen

We are working towards submitting your application. Thank you for your patience. An unknown error occurred, please input and try again.